Q-Collar: hope, hype, and another story of regulatory failure

How far will you go to promote your medical invention?This is a question for clinical innovators.How far will you go to market the invention?This is a question for corporations whose primary purpose is to keep pleasing their shareholders.The limits of promotion, of course, should be reached when the balance of benefits and harms is no longer favourable.That balance is a judgment, made by people capable of deciphering the evidence and seeking to protect the public-drug and device regulators, for example.